doi: 10.1007/s12011-015-0433-1 69
Other health issues include anemia, cystic fibrosis, cancer, Alzheimers, Parkinsons, cataracts, glaucoma, aging, alcoholism, hepatitis, memory loss, AIDS, chronic fatigue syndrome, osteoarthritis, and infertility in men
10.1111/j.1525-139X.2012.01081.x 95
Animal studies demonstrate that IGF-1 treatment reduces circulating free fatty acid levels, potentially through increased muscle uptake and oxidation combined with reduced adipose tissue lipolysis
The process involves knowing the amount of peptide in the vial (e.g., 5mg) and the amount of BW you add (e.g., 2ml)
The IGF-1 receptor consists of two alpha subunits and two beta subunits linked by disulfide bonds, forming a heterotetrameric structure